NURECA

Nureca Share Price

 

 

Start SIP in NURECA

Start SIP

Performance

  • Low
  • ₹286
  • High
  • ₹298
  • 52 Week Low
  • ₹204
  • 52 Week High
  • ₹448
  • Open Price₹289
  • Previous Close₹284
  • Volume28,531

Investment Returns

  • Over 1 Month + 1.28%
  • Over 3 Month + 28.7%
  • Over 6 Month + 2.95%
  • Over 1 Year + 0.67%

Smart Investing Starts Here Start SIP with Nureca for Steady Growth!

Invest Now

Nureca Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 71.4
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 293
  • P/B Ratio
  • 1.5
  • Average True Range
  • 11.34
  • EPS
  • 4.1
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.08
  • RSI
  • 56.07
  • MFI
  • 36.87

Nureca Financials

Nureca Technicals

EMA & SMA

Current Price
₹293.30
+ 9.55 (3.37%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹286.95
  • 50 Day
  • ₹279.56
  • 100 Day
  • ₹271.43
  • 200 Day
  • ₹269.74

Resistance and Support

292.18 Pivot Speed
  • R3 310.37
  • R2 303.93
  • R1 298.62
  • S1 286.87
  • S2 280.43
  • S3 275.12

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Nureca has an operating revenue of Rs. 130.12 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 1% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 11% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 17% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 36 which is a POOR score indicating inconsistency in earnings, a RS Rating of 82 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 131 indicates it belongs to a poor industry group of Medical-Products and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Nureca Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-28 Buy Back of Shares
2025-11-10 Buy Back of Shares
2025-10-16 Quarterly Results & Others To consider other business matters. per share(20%)Final Dividend
2025-07-15 Quarterly Results
2025-05-05 Audited Results
Date Purpose Remarks
2022-02-25 INTERIM Rs.3.00 per share(30%)Interim Dividend
View Nureca Dividend History Arrow

Nureca F&O

Nureca Shareholding Pattern

64.97%
0%
0%
0.07%
0%
32.15%
2.81%

About Nureca

  • NSE Symbol
  • NURECA
  • BSE Symbol
  • 543264
  • Chairman & Managing Director
  • Mr. Saurabh Goyal
  • ISIN
  • INE0DSF01015

Similar Stocks to Nureca

Nureca FAQs

Nureca share price is ₹293 As on 30 December, 2025 | 20:27

The Market Cap of Nureca is ₹293.3 Cr As on 30 December, 2025 | 20:27

The P/E ratio of Nureca is 71.4 As on 30 December, 2025 | 20:27

The PB ratio of Nureca is 1.5 As on 30 December, 2025 | 20:27

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23